Characterizing the RNA targets and position-dependent splicing regulation by TDP-43 JR Tollervey, T Curk, B Rogelj, M Briese, M Cereda, M Kayikci, J König, ... Nature neuroscience 14 (4), 452-458, 2011 | 1204 | 2011 |
A new method for the rapid and long term growth of human neural precursor cells CN Svendsen, MG ter Borg, RJE Armstrong, AE Rosser, S Chandran, ... Journal of neuroscience methods 85 (2), 141-152, 1998 | 766 | 1998 |
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study P Connick, M Kolappan, C Crawley, DJ Webber, R Patani, AW Michell, ... The Lancet Neurology 11 (2), 150-156, 2012 | 731 | 2012 |
Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations NH Alami, RB Smith, MA Carrasco, LA Williams, CS Winborn, SSW Han, ... Neuron 81 (3), 536-543, 2014 | 692 | 2014 |
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016 | 590 | 2016 |
Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1268-1283. e6, 2018 | 579 | 2018 |
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models SJ Barmada, A Serio, A Arjun, B Bilican, A Daub, DM Ando, A Tsvetkov, ... Nature chemical biology 10 (8), 677-685, 2014 | 445 | 2014 |
Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic … A Wilkins, H Majed, R Layfield, A Compston, S Chandran Journal of Neuroscience 23 (12), 4967-4974, 2003 | 417 | 2003 |
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability B Bilican, A Serio, SJ Barmada, AL Nishimura, GJ Sullivan, M Carrasco, ... Proceedings of the National Academy of Sciences 109 (15), 5803-5808, 2012 | 406 | 2012 |
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy A Serio, B Bilican, SJ Barmada, DM Ando, C Zhao, R Siller, K Burr, ... Proceedings of the National Academy of Sciences 110 (12), 4697-4702, 2013 | 392 | 2013 |
Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis PL Foley, HM Vesterinen, BJ Laird, ES Sena, LA Colvin, S Chandran, ... Pain® 154 (5), 632-642, 2013 | 367 | 2013 |
Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability AC Devlin, K Burr, S Borooah, JD Foster, EM Cleary, I Geti, L Vallier, ... Nature communications 6 (1), 5999, 2015 | 309 | 2015 |
Modeling ALS with motor neurons derived from human induced pluripotent stem cells S Sances, LI Bruijn, S Chandran, K Eggan, R Ho, JR Klim, MR Livesey, ... Nature neuroscience 19 (4), 542-553, 2016 | 302 | 2016 |
FUS-SMN protein interactions link the motor neuron diseases ALS and SMA T Yamazaki, S Chen, Y Yu, B Yan, TC Haertlein, MA Carrasco, JC Tapia, ... Cell reports 2 (4), 799-806, 2012 | 287 | 2012 |
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ... Nature genetics 53 (12), 1636-1648, 2021 | 280 | 2021 |
Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism P Hasel, O Dando, Z Jiwaji, P Baxter, AC Todd, S Heron, NM Márkus, ... Nature communications 8 (1), 15132, 2017 | 274 | 2017 |
Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells A Joannides, P Gaughwin, C Schwiening, H Majed, J Sterling, ... The Lancet 364 (9429), 172-178, 2004 | 247 | 2004 |
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial O Mosenzon, TM Blicher, S Rosenlund, JW Eriksson, S Heller, OH Hels, ... The lancet Diabetes & endocrinology 7 (7), 515-527, 2019 | 244 | 2019 |
Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration JR Smith, S Maguire, LA Davis, M Alexander, F Yang, S Chandran, ... Stem cells 26 (2), 496-504, 2008 | 244 | 2008 |
Lineage-specific distribution of high levels of genomic A Ruzov, Y Tsenkina, A Serio, T Dudnakova, J Fletcher, Y Bai, ... Cell research 21 (9), 1332-1342, 2011 | 234 | 2011 |